אתופן 300 ישראל - עברית - Ministry of Health

אתופן 300

taro pharmaceutical industries ltd - etodolac - קפסולות - etodolac 300 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אורסוליט 300 ישראל - עברית - Ministry of Health

אורסוליט 300

cts chemical industries ltd, israel - ursodeoxycholic acid - טבליה - ursodeoxycholic acid 300 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reduction in size of radiolucent cholesterol gallstones in patients with a functioning gallbladder. treatment of chronic liver diseases including primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia chronic hepatitis and alcoholic cirrhosis.

פלויקס 300 מ"ג ישראל - עברית - Ministry of Health

פלויקס 300 מ"ג

sanofi - aventis israel ltd - clopidogrel as hydrogen sulfate 300 mg - film coated tablets - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

פרופקס 300 מג ישראל - עברית - Ministry of Health

פרופקס 300 מג

taro pharmaceutical industries ltd - propafenone hydrochloride - טבליה - propafenone hydrochloride 300 mg - propafenone - propafenone - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

ונורוטון קפסולות 300 מ"ג ישראל - עברית - Ministry of Health

ונורוטון קפסולות 300 מ"ג

nutrition consumer health - monoxerutin 300 mg - capsules - monoxerutin - for the adjunctive treatment of varicose veins in all stages.

ונורוטון קפסולות 300 מג ישראל - עברית - Ministry of Health

ונורוטון קפסולות 300 מג

devries & co. ltd - oxerutines - קפסולות - oxerutines 300 mg - monoxerutin - monoxerutin - for the adjunctive treatment of varicose veins in all stages.

ראסילז 300 מ"ג ישראל - עברית - Ministry of Health

ראסילז 300 מ"ג

novartis pharma services ag - aliskiren 300 mg - film coated tablets - aliskiren - treatment of essential hypertension.

דלאצין סי כמוסות 300 מג ישראל - עברית - Ministry of Health

דלאצין סי כמוסות 300 מג

pfizer pfe pharmaceuticals israel ltd - clindamycin hydrochloride - קפסולות - clindamycin hydrochloride 300 mg - clindamycin - clindamycin - treatment of infections caused by susceptible anaerobic bacteria.

למיבודין  זידובודין טבע   150 מג  300 מג ישראל - עברית - Ministry of Health

למיבודין זידובודין טבע 150 מג 300 מג

abic marketing ltd, israel - lamivudine as anhydrous; zidovudine - טבליה - zidovudine 300 mg; lamivudine as anhydrous 150 mg - zidovudine - zidovudine - antiretroviral combination therapy for the treatment of hiv infected adults and adolescents over the age of 12 years.

אפיביר 300 מג ישראל - עברית - Ministry of Health

אפיביר 300 מג

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 300 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.